NV-HOHEM
8.1.2020 10:28:04 CET | Business Wire | Press release
CES 2020 will be held on January 7-10, 2020 in Las Vegas. During this grand gathering of global technology players, Hohem Technology Co., Ltd. (Hohem), as a dark horse in the portable gimbal industry, drew great attention of multiple buyers, journalists and third parties to its innovative and all-new smartphone gimbal iSteady X.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200108005299/en/
iSteady X, which will be officially launched in February 2020, is designed to solve the pain points of users with a foldable design and multiple creative functions like a 15-second video sharing button. Here are some highlights of the product.
The lightest
iSteady X stands out among others for it is the world's first lightweight handheld smartphone gimbal. Compared to traditional smartphone gimbals, iSteady X weighs only 249g, making it the world’s lightest three-axis smartphone gimbal. The lighter weight makes it easier to record your everyday life and journey.
Smaller
The foldable design makes iSteady X more compact and streamlined. Measuring only the size of a palm when folded up, it is convenient for users to carry around, hold in their hands, or put in their pockets, making it the ideal gadget for vloggers or those who like shooting with their smartphones.
Moment Mode, New Community APP
iSteady X has a set of buttons that allow users to instantly master the operation without pre-learning. Just by pressing one button, users can launch multiple modes including Moment Mode, Face-Tracking iSteady X is equipped with first-class anti-shake movement, the newest anti-shake algorithm iSteady, and the enhanced motor control scheme, so as to support a maximum load of 280g.
More information will not be released until its official release at CES 2020. Visitors at CES 2020 may go to booth 25953 to have a hand-on experience of Hohem products. Follow Hohem on Facebook : https://www.facebook.com/HohemGlobal/
About Hohem
Established in 2014, Hohem Technology Co., Ltd. (Hohem), adheres to its motto: Make the Moment, Enjoy it! It focuses on R&D and production of smart gimbals such as action camera gimbals, smartphone gimbals and DSLR gimbals.
The company has a solid technical foundation and has successfully launched the world’s first smartphone gimbal with face recognition function. Hohem is committed to providing users with simplistic, functional, and creative products. For details: https://www.hohem-tech.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20200108005299/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Landmark Global Galderma Survey Shows 9 out of 10 People Are Affected by Skin Quality Concerns7.7.2026 07:00:00 CEST | Press release
World’s most extensive skin quality profiling survey of more than 11,000 people across Europe, Asia, and the Americas finds that nine out of ten people are affected by skin quality concerns, with the most important attributes of good skin quality identified as smooth, hydrated and glowing skin1 Results show that skin quality has an impact on quality of life for 85% of people, with more than a third feeling self-conscious, insecure or anxious due to poor skin quality1 In response to clinicians’ calls for a universal assessment tool to help address these concerns, Galderma supported leading experts in the development of the Skin Quality Assessment Scale; a holistic, science-based tool to evaluate skin quality comprehensively and guide personalized, long-term treatment planning2 At Galderma, we champion skin quality by providing insights, tools, and solutions to better understand and address a wide spectrum of concerns, helping people take pride and feel comfortable in their own skin at e
Morinaga Milk Achieves Self-Affirmed GRAS Status for LAC-Living+™, Expanding U.S. Opportunities for Its Postbiotic Ingredient7.7.2026 04:00:00 CEST | Press release
Clinical evidence–backed postbiotic supports mood and well-being with formulation flexibility for diverse applications Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy and functional ingredient company, today announced that it has achieved self-affirmed GRAS (Generally Recognized As Safe) status in the United States for LAC-Living+™ (L. helveticus MCC1848), its proprietary postbiotic ingredient. This milestone expands the commercial availability of LAC-Living+ in the U.S. market and enables its use in dietary supplements, functional foods, and beverages, supporting the development of products designed to address growing consumer demand for health and well-being solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706806943/en/ Growing Interest in Postbiotics and Mental Well-Being Consumer interest in proactive health management has expanded significantly in recent years, alongside increasing aw
Access Advance Welcomes New Licensors to the Video Distribution Patent Pool7.7.2026 02:00:00 CEST | Press release
Access Advance LLC today announced that Sharp, M&K Holdings, Tagivan and 9 other patent owners who own substantial video codec patent portfolios that cover the core technologies behind video decoding, processing, and streaming media delivery, have joined the Video Distribution Patent Pool (VDP Pool) in the first half of 2026. "The addition of all of these new Licensors’ patent portfolios is a real win for both the VDP Pool and our many existing and future Licensees,” said Peter Moller, CEO of Access Advance. “These companies have broad and deep patent portfolios and further enhance the program’s market leading position in resolving the licensing issues around the use of modern video codecs across all the diverse business models of internet video streaming.” The following patent holders have joined the VDP Pool as Licensors in the first half of 2026: Digital Insights Inc. Hanbat National University Industry-Academic Cooperation Foundation Hanwha Vision Co., Ltd. Industry-Academy Coopera
Real Chemistry Announces New Asia Pacific Hub with Acquisition of Spurwing Communications in Singapore7.7.2026 01:00:00 CEST | Press release
Expanded footprint advances the company’s global strategy in key growth region for healthcare and pharma brands Real Chemistry, a global leader in AI- and insights-driven healthcare communications, today announced the acquisition of Spurwing Communications, establishing the company’s first Asia Pacific (APAC) strategic hub in Singapore. This milestone strengthens Real Chemistry’s global strategy and presence in APAC, enhancing its ability to support healthcare organizations. Combining deep market expertise with globally integrated capabilities across analytics, medical communications, advertising and strategic communications, the company is well positioned to deliver more connected, local insight-driven support — ultimately helping clients better reach and engage healthcare professionals, patients and caregivers across the region. “APAC is fast becoming one of the most dynamic and strategically important regions for healthcare innovation and access to life-improving therapies,” said Ka
Vertex to Acquire Crinetics Pharmaceuticals6.7.2026 22:04:00 CEST | Press release
- Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex’s portfolio - - PALSONIFY®, Crinetics’ recently launched, first and only, once-daily oral therapy for adults with acromegaly has demonstrated strong and growing early uptake - - Atumelnant, a once-daily oral adrenocorticotropic hormone (ACTH) receptor antagonist in Phase 3 development for congenital adrenal hyperplasia (CAH), has shown unique and transformative potential to both normalize androgen levels and enable management of patients with physiologic levels of glucocorticoids, the true goal of CAH management; atumelnant has also demonstrated therapeutic potential in patients with Cushing’s syndrome - - Acquisition adds to Vertex’s innovation pipeline, accelerates Vertex’s revenue growth and enhances long-term earnings profile - - Vertex to host investor call today, July 6 at 4:30 p.m. ET - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and C
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom